$9.360
-0.262 (-2.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PHAR por análisis de gráficos similares
Alphio's PHAR stock price prediction model matches the current Pharming Group NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.43 (+0.72%). The 1-week path is $9.47 (+1.14%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Pharming Group NV?
Pharming Group NV is not a good buy right now due to its current price of $9.36, which is significantly below the analyst price target range of $37 to $40. Additionally, the stock has a high forward P/E ratio of 212.77, indicating overvaluation concerns. The RSI is at 30.07, suggesting the stock is oversold, but this could indicate further downside risk rather than an immediate buying opportunity.
PHAR cerró en $9.36 el Friday, tras bajar -2.80%
Pharming Group NV (PHAR) last closed at $9.36, losing -2.80%. These facts feed the 1-day and 1-week PHAR price prediction above.
Factores de la previsión
Los factores de la previsión de Pharming Group NV (PHAR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PHAR, ordenadas por similitud.
Análisis de estacionalidad de PHAR
Historically the probability of a positive October return for PHAR is 39.66%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PHAR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $10.21 | $10.37 | $13.00 | +10.75% |
| Nov 2026 | $11.69 | $11.94 | $11.95 | +27.51% |
| Dec 2026 | $9.43 | $10.15 | $11.40 | +8.41% |
En 2026, se proyecta que Pharming Group NV (PHAR) oscile entre $9.43 y $13.00.
Previsión mensual de Pharming Group NV para 2026
En Oct de 2026, se proyecta que Pharming Group NV promedie $10.37, con un mínimo de $10.21 y un máximo de $13.00.
En Nov de 2026, se proyecta que Pharming Group NV promedie $11.94, con un mínimo de $11.69 y un máximo de $11.95.
En Dec de 2026, se proyecta que Pharming Group NV promedie $10.15, con un mínimo de $9.43 y un máximo de $11.40.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.